Core Viewpoint - Bayer is committed to enhancing its focus and resource investment in China's innovation ecosystem, aiming to collaborate with local innovators to discover the next significant breakthroughs in drug development [1]. Group 1: Competition Announcement - Bayer China has officially launched the "Co-Creation New Drug" competition, inviting Chinese innovators and biotechnology companies to submit and showcase their innovative research pipelines, drug molecules, or new technologies with breakthrough potential [1]. Group 2: Target Therapeutic Areas - The competition focuses on several key therapeutic areas, including: - Precision Oncology - Precision Cardiorenal Diseases - Immunology & Inflammation [2]. Group 3: Research Pipeline Stages - The competition accepts submissions at various stages of the research pipeline, ranging from early pre-clinical candidate compounds (pre-PCC) to clinical proof of concept (clinical PoC) [2]. Group 4: Drug Molecule Forms - Eligible drug molecule forms include: - Biologics - Small molecules (SMOL) - Conjugated drugs (XDC) - Genetic medicine - Small nucleic acid drugs (siRNA) - Molecular glue - Other platform technologies [3]. Group 5: Evaluation Criteria - Submissions will be evaluated by a review committee composed of Bayer China's and global R&D and business development experts based on innovation level, key data, advancement speed, and alignment with Bayer's R&D strategy [4].

Group 1 - The 27th China Beijing International Science and Technology Industry Expo (Beijing Sci-Tech Expo) will be held from May 8 to 11 at the National Convention Center, featuring a doubled exhibition area of approximately 50,000 square meters and over 800 participating enterprises and institutions [1][3] - The theme of this year's expo is "Technology Leading, Creating a Future," focusing on cutting-edge technology, emerging industries, and future industries, aiming to deepen international cooperation in technology and promote the integration of innovation, industry, finance, and talent [1][2] - A variety of activities will take place during the expo, including trade and investment promotion events, online display and matching, and a series of specialized forums and promotional meetings [3] Group 2 - The expo will showcase original achievements in foundational technologies such as quantum computing, gene editing, and flexible sensing technology, along with innovative products like room-temperature quantum computers and gene therapies for hereditary diseases [2] - Notable exhibits will include over 400 new achievements from the "Three Cities and One Area" and various sub-parks of Zhongguancun, featuring advanced technologies like reusable rockets and cutting-edge ophthalmic diagnostic equipment [2] - The upgraded online negotiation system will incorporate AI models to provide smarter and more precise services for participants, enhancing the overall experience of the expo [3]